Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON)

Journal of Magnetic Resonance Imaging

Volumn 27, Issue 5, 2008, Pages 1175-1180

  Korosoglou, Grigorios ^a,b   Tang, Lijun ^b   Kedziorek, Dorota ^b   Cosby, Kenyatta ^b   Gilson, Wesley D ^b   Vonken, Evert Jan ^b   Schär, Michael ^b,c   Sosnovik, David ^d   Kraitchman, Dara L ^b   Weiss, Robert G ^b   Weissleder, Ralf ^d   Stuber, Matthias ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PHILIPS HEALTHCARE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Inversion recovery with ON resonant water suppression (IRON); Magnetic resonance lymphography; Monocrystalline iron oxide nanoparticle (MION 47); Off resonance imaging

Indexed keywords

MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; NANOPARTICLE;

ANIMAL EXPERIMENT; ARTICLE; LYMPHOGRAPHY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; SIGNAL NOISE RATIO;

ABDOMEN; ANALYSIS OF VARIANCE; ANIMALS; CONTRAST MEDIA; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS; IRON; LYMPH NODES; MAGNETIC RESONANCE IMAGING; MALE; NANOPARTICLES; OXIDES; RABBITS;

EID: 42949145900     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21337     Document Type: Article

References (20)

1. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990;175:494-498.
2. Weissleder R, Heautot JF, Schaffer BK, et al. MR lymphography: study of a high-efficiency lymphotrophic agent. Radiology 1994;191:225-230.
3. Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994;193:501-506.
4. Choi SH, Han MH, Moon WK, et al. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer. Radiology 2006;241:753-762.
5. Choi SH, Moon WK, Hong JH, et al. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model. Radiology 2007;242:137-143.
6. Heesakkers RA, Futterer JJ, Hovels AM, et al. Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR imaging at 1.5 and 3.0 T: early experience. Radiology 2006;239:481-487.
7. Memarsadeghi M, Riedl CC, Kaneider A, et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus USPIO-enhanced MR imaging. Radiology 2006;241:367-377.
8. Anzai Y, Piccoli CW, Outwater EK, et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 2003;228:777-788.
9. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491-2499.
10. Koh DM, Brown G, Temple L, et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings - initial observations. Radiology 2004;231:91-99.
11. Bakker CJ, Seppenwoolde JH, Vincken KL. Dephased MRI. Magn Reson Med 2006;55:92-97.
12. Seppenwoolde JH, Viergever MA, Bakker CJ. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn Reson Med 2003;50:784-790.
13. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005;53:999-1005.
14. Mani V, Briley-Saebo KC, Hyafil F, Fayad ZA. Feasibility of in vivo identification of endogenous ferritin with positive contrast MRI in rabbit carotid crush injury using GRASP. Magn Reson Med 2006;56:1096-1106.
15. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med 2006;55:126-135.
16. Stuber M, Gilson W, Schar M, et al. Positive contrast visualization of iron oxide-labeled stem cells using inversion recovery with ON-resonant water suppression (IRON). Magn Reson Med 2007;58:1072-1077,
17. Shen T, Weissleder R, Papisov M, Bogdanov A Jr, Brady TJ. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 1993;29:599-604.
18. Wunderbaldinger P, Josephson L, Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem 2002;13:264-268.
19. Etienne A, Botnar RM, Van Muiswinkel AM, Boesiger P, Manning WJ, Stuber M. "Soap-Bubble" visualization and quantitative analysis of 3D coronary magnetic resonance angiograms. Magn Reson Med 2002;48:658-666.
20. Kraitchman DL, Tatsumi M, Gilson WD, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005;112:1451-1461.